223 related articles for article (PubMed ID: 29244610)
21. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
22. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
Khan GN; Kim EJ; Shin TS; Lee SH
Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
[TBL] [Abstract][Full Text] [Related]
23. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
[TBL] [Abstract][Full Text] [Related]
24. Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.
Liu M; Yin H; Qian X; Dong J; Qian Z; Miao J
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036030
[TBL] [Abstract][Full Text] [Related]
25. Exosome mediated communication within the tumor microenvironment.
Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells.
Nowakowska A; Tarasiuk J
Acta Biochim Pol; 2016; 63(3):571-5. PubMed ID: 27231728
[TBL] [Abstract][Full Text] [Related]
27. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
Deng Z; Rong Y; Teng Y; Zhuang X; Samykutty A; Mu J; Zhang L; Cao P; Yan J; Miller D; Zhang HG
Oncogene; 2017 Feb; 36(5):639-651. PubMed ID: 27345402
[TBL] [Abstract][Full Text] [Related]
28. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.
Kong JN; He Q; Wang G; Dasgupta S; Dinkins MB; Zhu G; Kim A; Spassieva S; Bieberich E
Int J Cancer; 2015 Oct; 137(7):1610-20. PubMed ID: 25833198
[TBL] [Abstract][Full Text] [Related]
29. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
[TBL] [Abstract][Full Text] [Related]
30. Functionalized DNA Enables Programming Exosomes/Vesicles for Tumor Imaging and Therapy.
Fan Z; Xiao K; Lin J; Liao Y; Huang X
Small; 2019 Nov; 15(47):e1903761. PubMed ID: 31614072
[TBL] [Abstract][Full Text] [Related]
31. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs.
Qiao L; Hu S; Huang K; Su T; Li Z; Vandergriff A; Cores J; Dinh PU; Allen T; Shen D; Liang H; Li Y; Cheng K
Theranostics; 2020; 10(8):3474-3487. PubMed ID: 32206102
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells.
Fang LM; Li B; Guan JJ; Xu HD; Shen GH; Gao QG; Qin ZH
Acta Pharmacol Sin; 2017 Sep; 38(9):1305-1316. PubMed ID: 28603284
[TBL] [Abstract][Full Text] [Related]
33. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
[TBL] [Abstract][Full Text] [Related]
34. Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin‑resistant breast cancer cells.
Wen C; Fu L; Huang J; Dai Y; Wang B; Xu G; Wu L; Zhou H
Mol Med Rep; 2019 Jun; 19(6):5162-5168. PubMed ID: 31059026
[TBL] [Abstract][Full Text] [Related]
35. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
36. Tumor-homing, pH- and ultrasound-responsive polypeptide-doxorubicin nanoconjugates overcome doxorubicin resistance in cancer therapy.
Wang Z; He Q; Zhao W; Luo J; Gao W
J Control Release; 2017 Oct; 264():66-75. PubMed ID: 28837822
[TBL] [Abstract][Full Text] [Related]
37. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
[TBL] [Abstract][Full Text] [Related]
38. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
40. ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells.
Hashemitabar S; Yazdian-Robati R; Hashemi M; Ramezani M; Abnous K; Kalalinia F
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
